Fast Five Quiz: Type 2 Diabetes Mellitus Comorbidities

Romesh Khardori, MD, PhD


January 30, 2020

ADA and ESC guidelines recommend aspirin therapy for secondary prevention of CAD in patients with type 2 DM based on evidence-based data establishing benefits of its use in this regard. For decades, aspirin therapy has been recommended for primary prevention of CAD, but more recent studies have demonstrated lack of benefit as a primary preventive agent for patients at moderate risk. Although aspirin is no longer recommended for primary prevention of CAD, both the ADA and ESC note that it may be considered for patients considered to be at high or very high risk for CAD.

Dietary modifications and glycemic control play an important role in reducing patients' risk for complications and comorbidities associated with type 2 DM, but these interventions alone are not sufficient to reduce CAD risk in this patient population.

Learn more about minimizing risk for CAD risk in patients with type 2 DM.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: